BPG is committed to discovery and dissemination of knowledge
Articles in Press
11/5/2026 8:34:52 AM | Browse: 7 | Download: 0
| Category |
Oncology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Oxaliplatin-induced pseudosepsis syndrome during FOLFOX-based hepatic arterial infusion chemotherapy for hepatocellular carcinoma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Hua-Yang Chen, Lin Xie, Han Qi, Shuang-Gang Chen, Yu-Jia Wang, Lu-Jun Shen, Zi-Lin Huang and Fei Cao |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| the National Natural Science Foundation of China |
82502489 |
|
| Corresponding Author |
Fei Cao, Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University Cancer Center, No. 651 Dongfeng East Road, Guangzhou 510060, Guangdong Province, China. caofei@sysucc.org.cn |
| Key Words |
Oxaliplatin; Pseudosepsis; Hepatic arterial infusion chemotherapy; Hepatocellular carcinoma; Procalcitonin |
| Core Tip |
We describe a previously underrecognized condition known as oxaliplatin-associated pseudosepsis syndrome that occurs during hepatic arterial infusion chemotherapy. It is characterized by high-grade fever, marked elevations in procalcitonin and interleukin-6 levels, transient hypotension, and occasional multiorgan dysfunction despite consistently negative blood cultures. The temporal pattern, universal recurrence upon rechallenge, and favorable response to supportive care strongly support a drug-associated inflammatory response rather than infection. Recognition of this entity is critical to avoid misdiagnosis, unnecessary antibiotic exposure, and treatment delays. In selected patients, substitution with alternative platinum agents may be considered, although further evidence is required. |
| Citation |
Chen HY, Xie L, Qi H, Chen SG, Wang YJ, Shen LJ, Huang ZL, Cao F. Oxaliplatin-induced pseudosepsis syndrome during FOLFOX-based hepatic arterial infusion chemotherapy for hepatocellular carcinoma. World J Gastrointest Oncol 2026; In press
|
| PDF |
126160-in-press.pdf
|
 |
Received |
|
2026-07-27 07:06 |
 |
Peer-Review Started |
|
2026-08-05 06:25 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2026-08-20 05:44 |
 |
Revised |
|
2026-08-31 03:18 |
 |
Publication Fee Transferred |
|
2026-10-21 02:09 |
 |
Second Decision by Editor |
|
2026-11-05 03:30 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-11-05 08:34 |
 |
Articles in Press |
|
2026-11-05 08:34 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.